«Zika vaccines protect mice from infection: NIH - funded research
suggests human vaccine is possible.»
Not exact matches
«Several letters [from the Association of American Medical Colleges and others]...
suggest that
human fetal tissue is used for modern
vaccine production.
The Walter Reed Army Institute of Research (WRAIR) and collaborators at the Beth Israel Deaconess Medical Center and Harvard Medical School have completed a promising preclinical study of two Zika
vaccine candidates that
suggests that an effective
human vaccine will be achievable.
Their experiments with lab - grown mouse and
human T - cells
suggest that people with cancer who have a greater variety of such receptors may respond better to immunotherapy drugs and
vaccines.
«Taken together, these two studies
suggest that the new scalable
vaccine formulation is likely to prove as effective as the original formulation — which would make it the first protective TB
vaccine in
humans since BCG, which was introduced almost a century ago,» said Professor Ajit Lalvani, Director of the Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London and a member of the DAR - 901 development team.
Research from Rutgers Cancer Institute of New Jersey shows that the «first in
human» series of
vaccine injections given directly into a pancreatic cancer tumor is not only well tolerated, but also
suggests an «encouraging» period of stable disease.
The version of RSV that naturally infects cattle is closely related to
human RSV, so the results
suggest that a similar
human RSV
vaccine construct may provide protection in
humans, according to the study authors.
This new work
suggests that anti-PD-1 antibodies might be equally effective in treating hepatitis C and other persistent
human viral infections, says Christopher Walker, PhD, a senior author on the study and director of the Center for
Vaccines and Immunity at Nationwide Children's.
Lack of preexisting virus - neutralizing antibodies in the
human population
suggests that these novel adenoviral recombinants may provide improved
vaccine carriers for use in
humans.
This research was in mice, so it can't directly translate to
humans, but it does
suggest that a
vaccine against Zika could spur protective antibodies that not only prevent people from getting the virus, but could protect a pregnant woman's fetus.
There are no
vaccines for preventing kennel cough in
humans so it is
suggested that anyone with compromised immunity should avoid contact with infected dogs.
Evidence
suggests that, like
humans, dogs and cats could be vaccinated with certain
vaccines early in life and be protected for a lifetime.
These results
suggest that tumor antigen loaded CD40 - B may serve as a practical alternative to DC in cell - based
vaccine strategies for both dogs and
humans with cancer.